Management of head and neck carcinomas with synchronous or metachronous oligometastatic disease: Role of locoregional radiotherapy and metastasis-directed radiotherapy
- 22 August 2023
- journal article
- research article
- Published by Elsevier in Cancer/Radiothérapie
- Vol. 28 (1) , 83-92
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Atypical Clinical Behavior of p16-Confirmed HPV-Related Oropharyngeal Squamous Cell Carcinoma Treated With Radical RadiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Oligometastases revisitedNature Reviews Clinical Oncology, 2011
- Pulmonary Metastasectomy for Pulmonary Metastases of Head and Neck Squamous Cell CarcinomasThe Annals of Thoracic Surgery, 2009
- Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung MetastasesJournal of Clinical Oncology, 2009
- Quality of life during first-line palliative chemotherapy for recurrent and metastatic head and neck cancer with weekly cisplatin and docetaxelJournal of Cancer Research and Clinical Oncology, 2008
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck CancerNew England Journal of Medicine, 2008
- Does Surgical Resection of Pulmonary Metastases of Head and Neck Cancer Improve Survival?Annals of Surgical Oncology, 2008
- Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapyJournal of Experimental Medicine, 2006
- Incidence and Sites of Distant Metastases from Head and Neck CancerORL, 2001
- No age limit for radical radiotherapy in head and neck tumoursEuropean Journal of Cancer, 1996